Use of a combination of pentoxifylline and type i...

Details Use of a combination of pentoxifylline and type i... Use of a combination of pentoxifylline and type i...

A - Human Necessities

61

K

A61K 38/21 (2006.01)

Patent

CA 2238770

The invention concerns the combined therapy of intermittent secondary progressive multiple sclerosis by the subcutaneous or intramuscular administration of type I interferons and the oral application of pentoxifylline, optionally in the controlled-release form.

L'invention concerne la thérapie combinée de la sclérose en plaques progressive secondaire évoluant par poussées successives, par administration sous-cutanée ou intramusculaire d'interférons de type I et administration par voie orale de pentoxifylline, éventuellement sous forme retard.

Affiliated with

Also associated with

Rating

Use of a combination of pentoxifylline and type i... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a combination of pentoxifylline and type i..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a combination of pentoxifylline and type i... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1945524